These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 2149487

  • 1. Ovarian response patterns to human menopausal gonadotropin in mixed hyperandrogenemia.
    Hamori M, Török A, Zwirner M, Tinneberg HR.
    Acta Endocrinol (Copenh); 1990 Dec; 123(6):598-602. PubMed ID: 2149487
    [Abstract] [Full Text] [Related]

  • 2. Androgen response in polycystic ovarian syndrome to FSH treatment after LHRH agonist suppression.
    Hamori M, Zwirner M, Clédon P, Tinneberg HR.
    Int J Fertil; 1992 Dec; 37(3):171-5. PubMed ID: 1355764
    [Abstract] [Full Text] [Related]

  • 3. Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis.
    Haning RV, Austin CW, Carlson IH, Kuzma DL, Zweibel WJ.
    Obstet Gynecol; 1985 Feb; 65(2):199-205. PubMed ID: 3155830
    [Abstract] [Full Text] [Related]

  • 4. Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction.
    Cedars MI, Steingold KA, de Ziegler D, Lapolt PS, Chang RJ, Judd HL.
    Fertil Steril; 1992 Mar; 57(3):495-500. PubMed ID: 1531463
    [Abstract] [Full Text] [Related]

  • 5. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
    Gonzalez F, Hatala DA, Speroff L.
    Am J Obstet Gynecol; 1991 Sep; 165(3):535-45. PubMed ID: 1832519
    [Abstract] [Full Text] [Related]

  • 6. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS, Thompson DL.
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [Abstract] [Full Text] [Related]

  • 7. Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. A cross-over study.
    Fulghesu AM, Lanzone A, Guida C, Nicoletti MC, Rossi P, Le Donne M, Caruso A, Mancuso S.
    J Reprod Med; 1992 Oct; 37(10):834-40. PubMed ID: 1479563
    [Abstract] [Full Text] [Related]

  • 8. Reduction of dehydroepiandrosterone sulfate synthesis in women with polycystic ovary syndrome by human menopausal gonadotropin but not purified urinary follicle stimulating hormone: a comparative pilot study.
    Turkmen S, Backstrom T, Idil M.
    Gynecol Endocrinol; 2004 Aug; 19(2):69-78. PubMed ID: 15624268
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.
    Chen F, Chen M, Zhang W, Yin H, Chen G, Huang Q, Yang X, Chen L, Lin C, Yin G.
    J Ovarian Res; 2021 Feb 14; 14(1):32. PubMed ID: 33583431
    [Abstract] [Full Text] [Related]

  • 10. Endocrinological environment with regard to the number of microcysts in patients with polycystic ovary syndrome.
    Yoshino K, Takahashi K, Eda Y, Okada S, Kitao M.
    Hum Reprod; 1992 Oct 14; 7(9):1201-4. PubMed ID: 1478997
    [Abstract] [Full Text] [Related]

  • 11. The effect of leuprolide acetate on ovulation induction with human menopausal gonadotropins in polycystic ovary syndrome.
    Dodson WC, Hughes CL, Whitesides DB, Haney AF.
    J Clin Endocrinol Metab; 1987 Jul 14; 65(1):95-100. PubMed ID: 2953752
    [Abstract] [Full Text] [Related]

  • 12. Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome.
    Veldhuis JD, Pincus SM, Garcia-Rudaz MC, Ropelato MG, Escobar ME, Barontini M.
    J Clin Endocrinol Metab; 2001 Aug 14; 86(8):3772-8. PubMed ID: 11502810
    [Abstract] [Full Text] [Related]

  • 13. Laparoscopic ovarian diathermy in the management of anovulatory infertility in women with polycystic ovaries: endocrine changes and clinical outcome.
    Armar NA, McGarrigle HH, Honour J, Holownia P, Jacobs HS, Lachelin GC.
    Fertil Steril; 1990 Jan 14; 53(1):45-9. PubMed ID: 2136836
    [Abstract] [Full Text] [Related]

  • 14. Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrhea.
    Carmina E, Fruzzetti F, Lobo RA.
    Am J Obstet Gynecol; 2016 Jun 14; 214(6):714.e1-6. PubMed ID: 26767792
    [Abstract] [Full Text] [Related]

  • 15. GnRH-agonist therapy in women with the polycystic ovarian syndrome: effects on ovarian volume and on gonadotropin and sex steroid levels.
    Dale PO, Tanbo T, Haug E, Abyholm T.
    Gynecol Endocrinol; 1989 Dec 14; 3(4):309-15. PubMed ID: 2516706
    [Abstract] [Full Text] [Related]

  • 16. Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment.
    Suikkari AM, MacLachlan V, Montalto J, Calderon I, Healy DL, McLachlan RI.
    Hum Reprod; 1995 Mar 14; 10(3):513-9. PubMed ID: 7782424
    [Abstract] [Full Text] [Related]

  • 17. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
    van der Westhuizen S, van der Spuy ZM.
    Ultrasound Obstet Gynecol; 1996 May 14; 7(5):335-41. PubMed ID: 8774098
    [Abstract] [Full Text] [Related]

  • 18. Normal ovarian function in a mild form of late-onset 3 beta-hydroxysteroid dehydrogenase deficiency.
    Medina M, Herrera J, Flores M, Martin O, Bermúdez JA, Zárate A.
    Fertil Steril; 1986 Dec 14; 46(6):1021-5. PubMed ID: 3023147
    [Abstract] [Full Text] [Related]

  • 19. Ovarian enlargement as a possible marker of androgen activity in polycystic ovary syndrome.
    Puzigaća Z, Prelević GM, Stretenović Z, Balint-Perić L.
    Gynecol Endocrinol; 1991 Sep 14; 5(3):167-74. PubMed ID: 1837973
    [Abstract] [Full Text] [Related]

  • 20. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome.
    Apter D, Bützow T, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1994 Jul 14; 79(1):119-25. PubMed ID: 8027216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.